جست‌وجوی استاد و پژوهشگر

Vikramaditya G. Yadavمشاهده پروفایل

دانشیار

• Biocatalysis
• Bioremediation
• Bioprocess engineering
• +۱۵ مورد دیگر

Vikramaditya G. Yadav is an Associate Professor at the University of British Columbia (UBC) in the Department of Chemical and Biological Engineering, Faculty of Applied Science. He directs the Master of Engineering Leadership (MEL) Program in Sustainable Process Engineering and leads the BioFoundry research group. Education: B.A.Sc., University of Waterloo (2007) Ph.D., Massachusetts Institute of Technology (2013) Postdoctoral Associate, Harvard University (2014) His research spans sustainable chemical manufacturing, metabolic engineering, and biotechnology. Key areas include: Designing biosynthetic enzymes for biomass valorization Developing bioremediation strategies for industrial water quality Creating innovative drug delivery systems and tissue engineering solutions Advancing synthetic biology for pharmaceutical and bioenergy applications His recent work focuses on ocular drug delivery, cannabinoid biosynthesis in E. coli, lignin-based nanoparticles for cancer therapy, and computational analysis of plant secondary metabolites. Collaborations with start-ups, industry, and medical labs drive innovation in Canada's bioeconomy. Professional Leadership: Chair, Biotechnology Division of the Chemical Institute of Canada Associate Editor, The Canadian Journal of Chemical Engineering He is affiliated with UBC's BioProducts Institute and contributes to project-based learning pedagogy.

Claus Lammمشاهده پروفایل

استاد

• Empathy
• Prosocial Behavior
• Social Neuroscience
• +۵ مورد دیگر

Claus Lamm is a Full Professor of Biological Psychology at the University of Vienna , where he leads the Social, Cognitive and Affective Neuroscience Unit (SCAN-Unit) . He serves as Vice Dean for Research and Advancement of Early Career Researchers at the Faculty of Psychology and holds affiliations with the Vienna Cognitive Science Hub , Environment & Climate Change Hub , and Austrian Academy of Sciences . His academic career spans international collaborations and formative research experience abroad. Scientific Focus: Lamm investigates the neural underpinnings of empathy and prosocial behavior , employing multi-modal approaches combining neuroimaging, psychopharmacology, and psychoneuroendocrinology . His work extends to comparative studies with ravens and dogs, and explores environmental social neuroscience through climate change decision-making research. Recent publications show trends in cross-cultural psychology , machine learning applications , and neurobiological pathways related to social behavior. Awards & Grants: Recipient of the APS Mentor Award for his support of early career researchers. Funded by European Research Council , Austrian Science Fund , Vienna Science and Technology Fund , and intramural grants exceeding €10 million. Key projects include "Unravelling the opioid system in empathy" and "Comparative dog-human fMRI" . Media Engagement: A prominent public science communicator, Lamm has appeared in Nature , Science Magazine , and Austrian media outlets like Ö1 Mittagsjournal and ORF2 , discussing topics from pandemic psychology to social media effects . He maintains active outreach through Science TV and educational programs .

• Neurosurgery
• Functional Neurosurgery
• Neuromodulation
• +۳ مورد دیگر

Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .

• Developmental Psychophysiology
• Temperament and Personality Development
• Neuroscience of Shyness and Social Anxiety
• +۴ مورد دیگر

Professor Louis Schmidt is a leading academic in the Department of Psychology, Neuroscience & Behaviour at McMaster University , with a research focus on developmental psychophysiology, temperament, and the long-term effects of early adversity. His work bridges neuroscience, psychology, and behavioral science, emphasizing the interplay between brain function and socio-emotional development across the lifespan. Key research themes: Shyness, social anxiety, autism spectrum disorder, schizophrenia, and outcomes of extremely low birth weight. Recognized for mentoring postdoctoral fellow Kristie Poole, who was celebrated as a role model in the Child Emotion Laboratory. Scientific Awards : Royal Society of Canada recognition for contributions to research and scholarship. Research Trends from 15 recent publications include: Neurophysiological mechanisms of shyness (EEG, ERP, RSA) Impact of antenatal corticosteroids on adult brain function Intergenerational effects of maternal mental health interventions Cross-cultural comparisons of temperamental shyness Developmental consequences of preterm birth Behavioral and neural correlates of social anxiety in diverse populations Grants & Collaborations : Led the SNACS randomized controlled trial on antenatal corticosteroids, with applications in obstetrics and developmental neuroscience. Collaborates extensively on topics like autism spectrum disorder, schizophrenia, and emotion regulation. Labs & Teams : Directs the Child Emotion Laboratory at McMaster University, fostering interdisciplinary research on developmental psychopathology and neural mechanisms of temperament.

Matthew W. Buczynskiمشاهده پروفایل

استادیار

• Neuroscience
• Drug Addiction
• Pharmacology
• +۳ مورد دیگر

Matthew W. Buczynski is an Assistant Professor at the School of Neuroscience , part of the College of Science at Virginia Tech . Holding a Ph.D. in Biochemistry from the University of California San Diego (2008) and postdoctoral training at The Scripps Research Institute (2009-2016), he joined Virginia Tech in August 2016 after completing his postdoctoral fellowship. Education: B.S. in Chemistry, University of Michigan , 2001 Ph.D. in Biochemistry, University of California San Diego , 2008 Postdoctoral Training, The Scripps Research Institute , 2009-2016 Dr. Buczynski’s research program focuses on identifying novel druggable targets for addiction and neurological disorders through mass spectrometry and behavioral pharmacology . His work integrates chemical biology , molecular pharmacology , and in vivo microdialysis to study molecular changes in the brain during chronic drug exposure. Key areas include nicotine dependence , ethanol withdrawal , and cross-talk between pain and addiction mechanisms. His recent publications highlight endocannabinoid system modulation , TRPV1/TRPA1 receptor activation in pain, and diacylglycerol lipase (DAGL) mechanisms in nicotine withdrawal. He employs both self-administration and forced exposure models to validate therapeutic targets. Prospective students can contact him directly through his lab’s website .

Markus Heiligمشاهده پروفایل

استاد

• Addiction Neuroscience
• Alcohol Dependence
• Neuropharmacology
• +۴ مورد دیگر

Markus Heilig is a Professor of Psychiatry and Head of the Department of Biomedical and Clinical Sciences (BKV) at Linköping University. He serves as Director of the Center for Social and Affective Neuroscience (CSAN), integrating basic and clinical neuroscience to address addictive and affective disorders. His work bridges neuropharmacology, molecular psychiatry, and clinical trials. Linköping University (Current) Center for Social and Affective Neuroscience (CSAN) (Director) Wallenberg Center for Molecular Medicine (Collaborator) His research focuses on alcohol dependence mechanisms, stress-neurotransmitter interactions (e.g., CRF, substance P, endocannabinoids), and personalized medicine approaches. Using animal models and human neuroimaging (fMRI), his lab explores epigenetic changes in frontal lobe and amygdala neurons that drive compulsive alcohol use. Recent publications highlight his work on endocannabinoid modulation for PTSD treatment, neural correlates of reward choices, and pharmacological interventions targeting GABA and opioid receptors. His studies often combine brain imaging, behavioral analysis, and pharmacology. Scientific awards include the 2019 Wallenberg Clinical Scholar grant and 2017 CAN/Nordic Drugs prizes. Heilig's research is supported by Vetenskapsrådet (SEK 57 million center funding) and international donations like the Andrew J. Bock Memorial Fund.

Rodolfo J. Floresمشاهده پروفایل

استادیار

• Behavioral Neuroscience
• Neuromodulators
• Prefrontal Cortex Function
• +۳ مورد دیگر

Dr. Rodolfo J. Flores serves as an Assistant Professor in the Department of Psychology within the College of Liberal Arts at the University of Texas at El Paso (UTEP). His primary research investigates neuromodulator function in the prefrontal cortex, with emphasis on acetylcholine and dynorphin systems during motivational conflict, stress responses, and addiction pathways. He employs advanced optogenetic and biosensor technologies to dissect neural circuitry underlying psychiatric conditions. Dr. Flores earned his Ph.D. in Social Cognitive and Neuroscience from UTEP in 2019, followed by postdoctoral training at the National Institute of Mental Health (NIMH). His work bridges molecular neuroscience with behavioral outcomes, focusing on how stress and substance exposure alter prefrontal cortical function. His research portfolio demonstrates consistent high-impact publication in top neuroscience journals including Nature Neuroscience , Neuron , and Psychoneuroendocrinology . Current work examines opioid neuropeptide dynamics, nicotine-alcohol interactions, and sex-specific hormonal influences on addiction behaviors. Methodologically, he specializes in genetically encoded biosensors and circuit-level manipulations to study threat processing and reward pathways. Dr. Flores teaches graduate and undergraduate courses including PSYC 4341 (Motivation & Emotion), thesis/dissertation supervision (PSYC 5395/6395), and research applications courses. His lab actively trains students through undergraduate research (RSRC 4033) and independent study opportunities (PSYC 4352).

• Computational Psychopathology
• Learning Theory
• Cognitive Neuroscience
• +۳ مورد دیگر

Robin A. Murphy is a Professor of Experimental Psychology at the University of Oxford and a Fellow and Tutor for Admissions at Corpus Christi College. He holds a PhD from McGill University (Canada) and has contributed over 50 scientific publications on associative learning mechanisms, their role in mental disorders like depression and psychopathy, and translational neuroscientific applications. His research bridges animal and human learning, with a focus on computational psychopathology and neurochemical modulation (e.g., serotonin). Education: Undergraduate degree, Queen's University MA and PhD in Psychology, McGill University Research Interests: Dr. Murphy investigates how associative learning processes underpin mental disorders, particularly through neurochemical systems like serotonin. His work explores causal reasoning biases in depression, psychopathy's learning deficits, and translational models linking animal studies to human cognition. Key themes include agency perception, contingency judgment, and the neural substrates of prejudice. Recent projects involve peptide research in aging and computational modeling of multi-agent systems in depression. Grants and Funding: Supported by MRC, BBSRC, Wellcome Trust, and Japan Society for the Promotion of Science. He has advised UK Research Councils and NSERC (Canada). Labs and Teams: Leads a lab focusing on associative learning mechanisms, collaborating with institutions globally on computational psychopathology and translational neuroscience.

Caryl Sortwellمشاهده پروفایل

استاد

• Parkinson's Disease
• Neurotrophic Factors
• Alpha-Synuclein Pathology
• +۴ مورد دیگر

Caryl E. Sortwell is a Professor of Translational Neuroscience and Edwin A. Brophy Endowed Chair in Central Nervous System Disorders at Michigan State University's College of Human Medicine. She leads the Sortwell Lab within the Neuroscience Program and Grand Rapids Research Center, focusing on Parkinson's disease (PD) therapeutics. Education : B.S. in Psychology/Pre-medicine (University of Illinois, 1987), Ph.D. in Anatomy and Cell Biology/Neurobiology (University of Illinois at Chicago, 1994) Positions : Assistant/Associate Professor at Rush University Medical Center (1997-2005), Associate Professor at University of Cincinnati (2005-2009), Professor at MSU College of Human Medicine (2009-present) Her research investigates alpha-synuclein pathology in PD using preformed fibril models to study neurodegeneration, neuroinflammation, and therapeutic interventions. She explores neurotrophic factors like BDNF, gene therapies targeting CaV1.3 channels, and deep brain stimulation mechanisms. Her work emphasizes precision medicine approaches to optimize treatment outcomes. Scientific contributions include methodological advancements in neurochemical sensing with diamond electrodes and viral vector delivery systems. Key collaborations include research with Dr. Joe Patterson on alpha-synuclein genetic consequences. Technical Expertise : Immunohistochemistry, stereotactic surgery, in vivo neurotoxicant models, protein analysis (Western blot/ELISA), droplet digital PCR, and neuroinflammatory profiling

Eduardo E. Benarrochمشاهده پروفایل

استاد

• Neurodegenerative disorders
• Autonomic disorders
• Parkinson's disease
• +۳ مورد دیگر

Eduardo E. Benarroch, M.D., is a Professor of Neurology and Consultant in the Department of Neurology at Mayo Clinic in Rochester, Minnesota. His research focuses on neurochemical mechanisms underlying neurodegenerative disorders such as multiple system atrophy (MSA) and Lewy body diseases, with emphasis on brainstem and hypothalamic neuronal groups controlling homeostasis. His work is supported by the MSA Coalition and has contributed to understanding autonomic, respiratory, and sleep symptom mechanisms in Parkinson's disease. Dr. Benarroch holds a D.Sci. in Physiology from Buenos Aires University and completed multiple fellowships including NIH Fogarty International Fellowship at Cornell University. He has held leadership roles including President of the American Autonomic Society and Co-Director of Mayo's Neuroscience Laboratory. His 286+ publications span neurochemical pathology, autonomic disorders, and clinical neurology. Awarded the AB Baker Lifetime Achievement Award in Neurologic Education, he has received repeated teaching honors including Mayo's Distinguished Educator Award. His professional memberships include American Academy of Neurology, Society for Neuroscience, and Sigma Xi. He has advised numerous trainees and contributed to consensus guidelines on dysphagia in neurodegenerative diseases.

• Neurodegenerative Diseases
• Environmental Toxicology
• Neurotoxicology
• +۴ مورد دیگر

Dr. Douglas Lobner is a Research Professor in the Department of Biomedical Sciences at Marquette University, College of Health Sciences. His research focuses on neurodegenerative disease mechanisms, environmental toxin interactions, and dental material toxicity. He investigates how environmental factors like mercury, pesticides, and BMAA interact with genetic predispositions to cause neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS, particularly through the cystine/glutamate transporter (system xc-). His work also explores dental pulp capping materials, emphasizing growth factor-enhanced repair mechanisms and system xc- regulation to prevent root canal procedures. Key collaborations involve studies on glutamate signaling, neurotoxicant synergy, and drug-induced neuroplasticity. Published research includes over 14 studies from 2009–2014, emphasizing system xc- regulation by growth factors, neurotoxin synergies (e.g., methylmercury and BMAA), and dental material toxicity mitigation strategies. His lab contributes to the Neuroscience Collaboratory and Integrative Neuroscience Research Center at Marquette.

David Sewellمشاهده پروفایل

مدرس ارشد

• Attention
• Learning
• Memory
• +۷ مورد دیگر

Dr. David Sewell is a Senior Lecturer and Deputy Head of School (Teaching & Learning) at the School of Psychology, The University of Queensland. His research focuses on attention, learning, memory, and decision-making, with a strong emphasis on formal mathematical models of human cognition. He is affiliated with the Centre for Perception and Cognitive Neuroscience within the Faculty of Health, Medicine and Behavioural Sciences. Education: Bachelor (Honours) of Arts and Doctor of Philosophy, both from the University of Western Australia. David's research explores the intersection of cognitive psychology and computational modeling. Key areas include perceptual decision-making, attentional mechanisms, and the application of diffusion models to understand cognitive processes. His work also extends to sustainability and collective self-regulation through cognitive frameworks. The 15 most recent articles highlight his contributions to modeling decision thresholds in memory prioritization, analyzing gaze cueing effects, and investigating neural correlates of confidence in multisensory decisions. Collaborative projects frequently involve interdisciplinary approaches, combining neuroscience, psychology, and computational methods. He has supervised multiple PhD candidates, serving as Principal or Associate Advisor, with research topics ranging from visual categorization to metacognition in children. Current and past funding includes ARC Discovery Projects on collective self-regulation and category learning constraints.

Gary Gibsonمشاهده پروفایل

استاد

• Neurodegeneration
• Alzheimer's Disease
• Parkinson's Disease
• +۷ مورد دیگر

Gary Gibson is a tenured Professor of Neuroscience at Weill Cornell Medicine and serves as Lab Director at the Burke Neurological Institute . He leads the Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration , focusing on age-related neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease . Educational background: Ph.D. in Physiology (Biochemistry/Neuroscience), Cornell University B.S. in Zoology and Chemistry, University of Wyoming His research investigates how mitochondrial dysfunction , reduced glucose metabolism , and oxidative stress contribute to neurodegeneration. He explores therapeutic interventions targeting these mechanisms, including benfotiamine for improving thiamine levels and modulating post-translational modifications of mitochondrial enzymes like the α-ketoglutarate dehydrogenase complex (KGDHC) . These studies integrate human autopsy samples, genetically modified cells , and transgenic mouse models to test hypotheses about calcium dysregulation, free radical damage, and inflammatory cascades. Recent publications highlight his work on mitochondrial enzyme plasticity , nutritional metabolism in dementia, and benfotiamine's neuroprotective effects in clinical trials. He has secured continuous NIH funding (Grant R01AG043679) and holds three U.S. patents . Dr. Gibson serves on editorial boards for Neurochemical Research , Neurochemical International , and Journal of Neurochemistry , and has mentored undergraduate students and postdoctoral researchers .

Ian Greenhouseمشاهده پروفایل

استادیار

• Motor Control
• Action Stopping
• Neurophysiology
• +۳ مورد دیگر

Ian Greenhouse serves as an Assistant Professor in the Department of Human Physiology within the College of Arts and Sciences at the University of Oregon. He directs the Action Control Laboratory, where he investigates the neurophysiological mechanisms underlying human movement initiation and cancellation using multimodal approaches including electrophysiology, neuroimaging, and brain stimulation. Education: Undergraduate degree in Psychology from Tufts University Ph.D. from the University of California, San Diego Postdoctoral training at the University of California, Berkeley Research Focus: Dr. Greenhouse's work centers on action control neurophysiology , specifically examining motor inhibition processes during response stopping and preparation. His lab employs electromyography (EMG) , transcranial magnetic stimulation (TMS) , and magnetic resonance spectroscopy (MRS) to probe corticospinal excitability in healthy and clinical populations. Key investigations include neural computations for action preparation, biomarkers of stopping failure, and relationships between motor performance and brain chemistry (e.g., GABA). Publication Trends: Analysis of Dr. Greenhouse's 2022-2025 publications reveals intensified focus on subcomponents of response inhibition (pause vs. cancel processes) and neurochemical modulation of motor control. His work increasingly integrates menstrual cycle effects on GABA with action stopping metrics, while maintaining core investigations of corticospinal dynamics during unimanual/bimanual preparation. Recent studies show growing clinical applications in stroke rehabilitation. Scientific Awards: No awards were documented in the source materials. Advising and Research: As laboratory director, Dr. Greenhouse mentors students in the Action Control Laboratory's research program. Although specific grants aren't detailed, his high-output publication record spanning neuroimaging, electrophysiology, and clinical applications suggests sustained external funding for equipment-intensive neuroscience research. Laboratory Operations: The Action Control Laboratory (https://actioncontrollab.uoregon.edu) operates from Gerlinger Hall (Room 348), utilizing TMS-EMG integration, MRS, and behavioral paradigms to study action control. Current projects examine preparatory inhibition in stroke recovery, interhemispheric dynamics during movement preparation, and individual differences in stopping processes using the stop-signal task framework.

Rosalyn Moranمشاهده پروفایل

استاد

• Computational Neuroscience
• Computational Psychiatry
• Neurodegenerative Diseases
• +۵ مورد دیگر

Professor Rosalyn Moran is a Professor of Computational Neuroscience and Deputy Director of King's Institute for Artificial Intelligence at King's College London. She holds roles in the Department of Neuroimaging and School of Neuroscience within the Institute of Psychiatry, Psychology & Neuroscience. Her research focuses on computational neuroscience, computational psychiatry, and neurology, particularly integrating brain connectivity with algorithmic principles like the free energy principle. She explores neurotransmitter roles in decision-making and disease modeling, with applications in artificial intelligence and neurodegenerative disorders. Moran serves as an editor for Neuroimage and collaborates with leading institutions. Key projects include global neuroimaging initiatives (UNITY) and low-field MRI advancements in low-resource settings. Her work bridges Bayesian inference, AI, and neurobiology, with recent emphasis on pediatric neuroimaging and treatment-resistant psychosis. Education & Research Interests Rosalyn Moran's research spans computational psychiatry, neuroimaging techniques, and AI applications in healthcare. Her lab investigates serotonin and dopamine signaling, brain connectivity patterns, and predictive coding frameworks. Notable contributions include modeling NMDA receptor dysfunction in encephalitis and developing super-resolution MRI methods for global health contexts. Grants & Collaborations Funded projects include MRC Human Functional Genomics (2024-2028), NIHR Maudsley BRC (2022-2027), and Gates Foundation initiatives for low-field MRI enhancement. Collaborators include Karl Friston (UCL), Read Montague (Virginia Tech), and Klaas Enno Stephan (University of Zurich). Recent events include presenting the Free Energy Principle's role in generative AI (May 2023). Labs & Teams Her lab focuses on computational psychiatry and AI-driven neuroimaging solutions, collaborating with the King’s Global Health Institute to advance medical imaging accessibility in low-income regions.